Author | Lightnews

Matthew Robinson @pa4gps.bsky.social · 6d

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for October 2025. This update is a call to action to improve patient safety linked to #MedSafetyWeek. This is an annual campaign taking place from 3 to... https://www.prescriber.org.uk/?p=1867

Matthew Robinson @pa4gps.bsky.social · 10d

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of October 2025. This month there is one technology appraisal and one guideline that impact upon primary care. The Mirabegron for treating... https://www.prescriber.org.uk/?p=1866

Matthew Robinson @pa4gps.bsky.social · 16d

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Linzagolix (Yselty®) has been accepted for use in adult women of reproductive age for symptomatic treatment of endometriosis in women with a history of... https://www.prescriber.org.uk/?p=1865

Matthew Robinson @pa4gps.bsky.social · 21d

The Department of Health and Social Care has recently announced a change to the prescribing restrictions for antiviral medicines for influenza. The requirement that an notification be issued by the Chief Medical Officer has been removed. Prescribing of... https://www.prescriber.org.uk/?p=1864

Matthew Robinson @pa4gps.bsky.social · 24d

During September 2025 Clinical Knowledge Summaries were published or updated in the following areas. Acute childhood limp Addison's disease Baker's cyst Constipation in children Glaucoma Multiple myeloma Tiredness/fatigue in adults All of the topics have... https://www.prescriber.org.uk/?p=1863

Matthew Robinson @pa4gps.bsky.social · Sep 26

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of September 2025. This month there are two technology appraisals, five guidelines and two health technology evaluations that impact upon... https://www.prescriber.org.uk/?p=1862

Matthew Robinson @pa4gps.bsky.social · Sep 24

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for September 2025. This update reminds and reassures patients and clinicians that there is no evidence that taking paracetamol during pregnancy causes... https://www.prescriber.org.uk/?p=1861

Matthew Robinson @pa4gps.bsky.social · Sep 8

The manufacturer of Levemir® (insulin detemir) has announced a decision to discontinue this product in both the pre-filled pens (FlexPen) and cartridges with supplies expected to exhausted by the end of 2026. The Specialist Pharmacy Service offers more... https://www.prescriber.org.uk/?p=1860

Matthew Robinson @pa4gps.bsky.social · Sep 3

During August 2025 Clinical Knowledge Summaries were published or updated in the following areas. Bone and soft tissue sarcoma - recognition and referral Brain and central nervous system cancers - recognition and referral Breast cancer - recognition and... https://www.prescriber.org.uk/?p=1859

Matthew Robinson @pa4gps.bsky.social · Aug 28

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of August 2025. This month there is one health technology evaluation that impacts upon primary care. The Compression products for treating... https://www.prescriber.org.uk/?p=1858

Matthew Robinson @pa4gps.bsky.social · Aug 5

During July 2025 Clinical Knowledge Summaries were published or updated in the following areas. Coeliac disease Diabetes - type 2 Falls - assessment Immunizations - childhood Immunizations - travel Insulin therapy in type 2 diabetes Jaundice in adults... https://www.prescriber.org.uk/?p=1857

Matthew Robinson @pa4gps.bsky.social · Jul 31

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of July 2025. This month there are two technology appraisals and one health technology evaluation that impact upon primary care. The... https://www.prescriber.org.uk/?p=1856

Matthew Robinson @pa4gps.bsky.social · Jul 18

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for July 2025. This update warns clinicians about a small increase in the risk of Guillain-Barré syndrome following vaccination with respiratory... https://www.prescriber.org.uk/?p=1855

Matthew Robinson @pa4gps.bsky.social · Jul 9

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Fezolinetant (Veoza®) has been rejected for use in the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. The submitting... https://www.prescriber.org.uk/?p=1854

Matthew Robinson @pa4gps.bsky.social · Jul 2

During June 2025 Clinical Knowledge Summaries were published or updated in the following areas. Corticosteroids - oral Hand, foot, and mouth disease Hepatitis C Immunizations - seasonal influenza Jaundice in the newborn Myalgic encephalomyelitis/chronic... https://www.prescriber.org.uk/?p=1853

Matthew Robinson @pa4gps.bsky.social · Jun 23

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of June 2025. This month there is one guideline, one technology appraisal and one health technology evaluation that impact upon primary care.... https://www.prescriber.org.uk/?p=1852

Matthew Robinson @pa4gps.bsky.social · Jun 20

The Medicines and Healthcare products Regulatory Agency (MHRA) has published two Drug Safety Update articles for June 2025. Earlier this month updated safety and educational materials were made available to support the implementation of the regulatory... https://www.prescriber.org.uk/?p=1851

Matthew Robinson @pa4gps.bsky.social · Jun 10

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Bempedoic acid (Nilemdo®) has been rejected for use in adults with established or at high risk for atherosclerotic cardiovascular disease to reduce... https://www.prescriber.org.uk/?p=1850

Matthew Robinson @pa4gps.bsky.social · Jun 4

During May 2025 Clinical Knowledge Summaries were published or updated in the following areas. Appendicitis Corticosteroids - inhaled Cough Dupuytren's disease Menopause Neck lump Pityriasis versicolor Vitiligo All of the topics have been reviewed and... https://www.prescriber.org.uk/?p=1849

Matthew Robinson @pa4gps.bsky.social · May 28

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of May 2025. This month there is one guideline and one technology appraisal that impact upon primary care. The Suspected cancer: recognition... https://www.prescriber.org.uk/?p=1848

Matthew Robinson @pa4gps.bsky.social · May 20

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update for May 2025. This update warns clinicians of an increased risk of intrahepatic cholestasis of pregnancy (ICP) associated with thiopurines (azathioprine,... https://www.prescriber.org.uk/?p=1847

Matthew Robinson @pa4gps.bsky.social · May 6

During April 2025 Clinical Knowledge Summaries were published or updated in the following areas. Bronchiectasis Cataracts Chronic pain Itch in pregnancy Pityriasis rosea All of the topics have been reviewed and updated with minor structural and layout... https://www.prescriber.org.uk/?p=1846

Matthew Robinson @pa4gps.bsky.social · May 1

The Department of Health and Social Care has announced that NHS prescription charges will be frozen for the first time in 3 years to help with the cost of living. Charges for prescriptions will remain at £9.90 for a single charge or £32.05 for a 3-month... https://www.prescriber.org.uk/?p=1845

1

Matthew Robinson @pa4gps.bsky.social · Apr 29

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of April 2025. This month there are two guidelines that impact upon primary care. The Suspected cancer: recognition and referral guideline has... https://www.prescriber.org.uk/?p=1844

Matthew Robinson @pa4gps.bsky.social · Apr 25

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a second Drug Safety Update for April 2025. This update reminds healthcare professionals and patients of the risk of severe asthma attacks and increased mortality associated with... https://www.prescriber.org.uk/?p=1843